We would like to thank the Australian Research Council for funding (ARC Discovery Project: 0986632) and Dr. Kelvin Picker and Dr. Keith Fisher for technical support.
Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer†
Article first published online: 7 JAN 2011
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Angewandte Chemie International Edition
Volume 50, Issue 7, pages 1635–1639, February 11, 2011
How to Cite
Wilkinson, B. L., Day, S., Malins, L. R., Apostolopoulos, V. and Payne, R. J. (2011), Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer. Angew. Chem. Int. Ed., 50: 1635–1639. doi: 10.1002/anie.201006115
- Issue published online: 9 FEB 2011
- Article first published online: 7 JAN 2011
- Manuscript Revised: 27 OCT 2010
- Manuscript Received: 30 SEP 2010
- Australian Research Council. Grant Number: 0986632
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.